{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:58:40Z","timestamp":1784091520869,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatoblastoma (HB) is identified to be the most common liver malignancy which occurs in children. Long non-coding RNAs (lncRNAs) have been implicated in numerous biological processes and diseases, including HB. LncRNA MIR205 host gene (MIR205HG) has been investigated in multiple cancers, however, its role in HB remains to be elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MIR205HG expression was analyzed by RT-qPCR. EdU, colony formation and transwell assays were implemented to measure the biological function of MIR205HG on the progression of HB. Mechanism assays were carried out to probe into the underlying mechanism of MIR205HG in HB cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MIR205HG was significantly overexpressed in HB. Moreover, MIR205HG inhibition suppressed the proliferative, migratory and invasive capacities of HB cells. Furthermore, MIR205HG competitively bound to microRNA-514a-5p (miR-514a-5p) and targeted mitogen-activated protein kinase 9 (MAPK9) to stimulate mitogen activated protein kinase (MAPK) signaling pathway. Besides, MIR205HG also served as a sponge for microRNA-205-5p (miR-205-5p) to activate the PI3K\/AKT signaling pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MIR205HG drives the progression of HB which might provide an efficient marker and new therapeutic target for HB.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13062-021-00309-3","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T10:02:43Z","timestamp":1641549763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["LncRNA MIR205HG accelerates cell proliferation, migration and invasion in hepatoblastoma through the activation of MAPK signaling pathway and PI3K\/AKT signaling pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"2","key":"309_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","volume":"34","author":"D Sharma","year":"2017","unstructured":"Sharma D, Subbarao G, Saxena R. Hepatoblastoma. Semin Diagn Pathol. 2017;34(2):192\u2013200.","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"309_CR2","first-page":"136","volume":"11","author":"JT Stocker","year":"1994","unstructured":"Stocker JT. Hepatoblastoma. Semin Diagn Pathol. 1994;11(2):136\u201343.","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"309_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","volume":"5","author":"CE Herzog","year":"2000","unstructured":"Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist. 2000;5(6):445\u201353.","journal-title":"Oncologist"},{"issue":"3","key":"309_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/00015458.2004.11679562","volume":"104","author":"L Abbaso\u011flu","year":"2004","unstructured":"Abbaso\u011flu L, G\u00fcn F, Tansu Salman F, Relik A, Saraq F, Un\u00fcvar A, et al. Hepatoblastoma in children. Acta Chir Belg. 2004;104(3):318\u201321.","journal-title":"Acta Chir Belg"},{"issue":"1","key":"309_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.sempedsurg.2011.10.011","volume":"21","author":"D von Schweinitz","year":"2012","unstructured":"von Schweinitz D. Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg. 2012;21(1):21\u201330.","journal-title":"Semin Pediatr Surg"},{"issue":"3","key":"309_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00008480-199606000-00016","volume":"8","author":"JD Geiger","year":"1996","unstructured":"Geiger JD. Surgery for hepatoblastoma in children. Curr Opin Pediatr. 1996;8(3):276\u201382.","journal-title":"Curr Opin Pediatr"},{"key":"309_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.acc.2019.08.003","volume":"95","author":"R Choudhari","year":"2020","unstructured":"Choudhari R, Sedano MJ, Harrison AL, Subramani R, Lin KY, Ramos EI, et al. Long noncoding RNAs in cancer: From discovery to therapeutic targets. Adv Clin Chem. 2020;95:105\u201347.","journal-title":"Adv Clin Chem"},{"issue":"36","key":"309_CR8","doi-asserted-by":"publisher","first-page":"e12131","DOI":"10.1097\/MD.0000000000012131","volume":"97","author":"T Li","year":"2018","unstructured":"Li T, Chen Y, Zhang J, Liu S. LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells. Medicine. 2018;97(36):e12131.","journal-title":"Medicine"},{"issue":"1","key":"309_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/2211-5463.12732","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Wang Q, Teng L, Zhang J, Song J, Bo W, et al. LncRNA DANCR promotes proliferation and metastasis in pancreatic cancer by regulating miRNA-33b. FEBS Open Bio. 2020;10(1):18\u201327.","journal-title":"FEBS Open Bio"},{"key":"309_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.gene.2018.08.038","volume":"679","author":"S Yan","year":"2018","unstructured":"Yan S, Shan X, Chen K, Liu Y, Yu G, Chen Q, et al. LINC00052\/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma. Gene. 2018;679:138\u201349.","journal-title":"Gene"},{"key":"309_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biopha.2018.02.026","volume":"101","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Liu F, Yang F, Liu Y. Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1. Biomed Pharmacother. 2018;101:14\u201323.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"309_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000505131","volume":"87","author":"LJ Chen","year":"2020","unstructured":"Chen LJ, Yuan MX, Ji CY, Zhang YB, Peng YM, Zhang T, et al. Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203\/VEGFA Axis. Pathobiol: J Immunopathol Mol Cell Biol. 2020;87(3):161\u201370.","journal-title":"Pathobiol: J Immunopathol Mol Cell Biol"},{"key":"309_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fcell.2019.00271","volume":"7","author":"X Cui","year":"2019","unstructured":"Cui X, Wang Z, Liu L, Liu X, Zhang D, Li J, et al. The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF\/c-Met Pathway. Front Cell Develop Biol. 2019;7:271.","journal-title":"Front Cell Develop Biol"},{"key":"309_CR14","doi-asserted-by":"publisher","first-page":"13097","DOI":"10.2147\/OTT.S286627","volume":"13","author":"H Li","year":"2020","unstructured":"Li H, Jia J, Yang L, Chu J, Sheng J, Wang C, et al. LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214\/SOX4 Axis. Onco Targets Ther. 2020;13:13097\u2013109.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"309_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12890-020-1174-2","volume":"20","author":"L Liu","year":"2020","unstructured":"Liu L, Li Y, Zhang R, Li C, Xiong J, Wei Y. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p\/MAP3K2 axis. BMC Pulm Med. 2020;20(1):163.","journal-title":"BMC Pulm Med"},{"key":"309_CR16","doi-asserted-by":"publisher","first-page":"104322","DOI":"10.1016\/j.yexmp.2019.104322","volume":"111","author":"M Dong","year":"2019","unstructured":"Dong M, Dong Z, Zhu X, Zhang Y, Song L. Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1. Exp Mol Pathol. 2019;111:104322.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"309_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.068692.118","volume":"25","author":"G Michlewski","year":"2019","unstructured":"Michlewski G, C\u00e1ceres JF. Post-transcriptional control of miRNA biogenesis. RNA (New York, NY). 2019;25(1):1\u201316.","journal-title":"RNA (New York, NY)"},{"issue":"5","key":"309_CR18","first-page":"1677","volume":"42","author":"J Huang","year":"2019","unstructured":"Huang J, Wang X, Wen G, Ren Y. miRNA-205-5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K\/Akt\/mTOR signaling in renal carcinoma cells. Oncol Rep. 2019;42(5):1677\u201388.","journal-title":"Oncol Rep"},{"issue":"5","key":"309_CR19","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s13277-015-3346-x","volume":"36","author":"S Ergun","year":"2015","unstructured":"Ergun S, Oztuzcu S. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol. 2015;36(5):3129\u201336.","journal-title":"Tumour Biol"},{"issue":"6","key":"309_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600\u20134.","journal-title":"J Recept Signal Transduct Res"},{"issue":"19","key":"309_CR21","first-page":"9981","volume":"24","author":"ZX Wang","year":"2020","unstructured":"Wang ZX, Zhao Y, Wang YB, Zhang Q, Zou QX, Liang FH, et al. CircRNF20 aggravates the progression of non-small-cell lung carcinoma by activating MAPK9. Eur Rev Med Pharmacol Sci. 2020;24(19):9981\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"309_CR22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/ijlh.13055","volume":"41","author":"M Zhao","year":"2019","unstructured":"Zhao M, Zhang Y, Liu Y, Sun G, Tian H, Hong L. Polymorphisms in MAPK9 (rs4147385) and CSF1R (rs17725712) are associated with the development of inhibitors in patients with haemophilia A in North China. Int J Lab Hematol. 2019;41(4):572\u20137.","journal-title":"Int J Lab Hematol"},{"issue":"19","key":"309_CR23","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.1073\/pnas.0502143102","volume":"102","author":"A Jaeschke","year":"2005","unstructured":"Jaeschke A, Rinc\u00f3n M, Doran B, Reilly J, Neuberg D, Greiner DL, et al. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc Natl Acad Sci USA. 2005;102(19):6931\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"309_CR24","doi-asserted-by":"crossref","unstructured":"Liu M, Jia J, Wang X, Liu Y, Wang C. Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143\u20133p. Cancer Biol Therapy. 2018.","DOI":"10.1080\/15384047.2018.1423921"},{"issue":"38","key":"309_CR25","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1073\/pnas.1110977109","volume":"109","author":"P Tucci","year":"2012","unstructured":"Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA. 2012;109(38):15312\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"309_CR26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/CMAR.S231872","volume":"12","author":"YP Liu","year":"2020","unstructured":"Liu YP, Wan J, Long F, Tian J, Zhang C. circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p\/c-FLIP Axis in Osteosarcoma. Cancer Manag Res. 2020;12:1229\u201340.","journal-title":"Cancer Manag Res"},{"key":"309_CR27","doi-asserted-by":"crossref","unstructured":"Zhu H, Shan Y, Ge K, Lu J, Kong W, Jia C. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205\u20135p. Pancreatol: Off J Int Assoc Pancreatol (IAP) 2020;20(6):1139\u201348.","DOI":"10.1016\/j.pan.2020.05.004"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-021-00309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-021-00309-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-021-00309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T13:42:42Z","timestamp":1700055762000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-021-00309-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s13062-021-00309-3","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mice experiments were approved by the First Affiliated Hospital of Hebei North University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}